
FDA perspectives on specs and effective control strategies.
Ruth V. Cordoba-Rodriguez, PhD, is a biologist at the division of monoclonal antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, US Food and Drug Administration

FDA perspectives on specs and effective control strategies.

Published: November 1st 2008 | Updated: